As predicted by the SOMAscan® 1.3K assay, we successfully validated the GBM cluster-specific changes for CD59, FN1, STAT1, and STAT6 proteins in GBM cells and, for STAT6, also in corresponding GBM tissues. The gene discussed is CD59; the disease is glioblastoma.